This article needs additional citations for verification. (December 2022) |
Underrepresented populations, especially black and hispanic populations with cystic fibrosis are often not successfully diagnosed.[1] This is in part due to the minimal dissemination of existing data on patients from these underrepresented groups. While white populations do appear to experience a higher frequency of cystic fibrosis, other ethnicities are also affected and not always by the same biological mechanisms.[2] Thus, many healthcare and treatment options are less reliable or unavailable to underrepresented populations. This issue affects the level at which public health needs are being met across the world.